ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Outcome"

  • 2018 American Transplant Congress

    Higher Concordance in the Incidence of DGF and Post-Transplant BKV Infection among Recipients Receiving Mate Kidneys from the Same Deceased Donor: A Paired Deceased Donor Kidney Transplant Analysis

    K. Venkatesh,1 C. Wu,1 C. Puttarajappa,1 R. Mehta,1 P. Sood,1 A. Tevar,2 S. Hariharan.1

    1Nephrology Division, Univ of Pittsburgh Medical Center, Pittsburgh, PA; 2Transplant Surgery, Univ of Pittsburgh Medical Center, Pittsburgh, PA.

    Background: This study was undertaken to explore the degree to which donor variables impact rates of DGF, post-transplant CMV and BKV infections using a paired…
  • 2018 American Transplant Congress

    Mycoplasma hominis Infection in Lung Transplant Recipients: A Retrospective Case Series

    J. Wright,1,2 N. Law,4 M. Murray, S. Poutanen,1,2 S. Husain,1 S. Keshavjee,1 L. Singer,1 A. Humar,1 D. Kumar.1

    1UHN, Toronto, ON, Canada; 2University of Toronto, Toronto, ON, Canada; 3UC-San Diego, San Diego.

    Background: Mycoplasma hominis is increasingly recognized as a respiratory pathogen causing invasive disease in solid organ transplant (SOT) recipients. We reviewed the clinical characteristics, management…
  • 2018 American Transplant Congress

    Excellent Long Term Outcomes Transplanting Single Pediatric Kidneys from Donors Five Years and Younger into Adult Recipients

    R. Shah,1 M. Aull,2 A. Watkins,2 S. Kapur.2

    1Department of Surgery, Lincoln Medical Center, New York, NY; 2Surgery/Transplant Surgery, NewYork-Presbyterian/Weill Cornell Medical College, New York, NY.

    Pediatric kidneys have been traditionally considered marginal organs for transplantation & are underutilized given concerns of poor outcomes. Furthermore, long term outcomes of single kidneys…
  • 2018 American Transplant Congress

    Liver Transplantation with or without Left Renal Vein Ligation: Comparative Study of 105 Cases

    M. Perosa,1 H. Noujaim,1 J. Branez,1 L. Mota,1 B. Zeballos,1 R. Santos,1 A. Watanabe,2 G. Ferreira,2 A. Moraes,2 A. Silvestre,3 G. Martinho,4 N. Siqueira,5 T. Genzini.1

    1Abdominal Organ Transplantation, Leforte Hospital, Sao Paulo, Brazil; 2ICDF Hospital, Brasilia, Brazil; 3Medical School, Sao Camilo, Sao Paulo, Brazil; 4Medical School, Santa Casa, Sao Paulo, Brazil; 5Hospital das Clínicas, Rio Branco, Acre, Brazil.

    The presence of large spontaneous splenorenal shunts (SSRS) is a risk factor for low portal flow and graft dysfunction after liver transplantation (LT). Left renal…
  • 2018 American Transplant Congress

    Belatacept Maintenance Immunosuppression Use and Outcomes in the Real-World Clinical Setting Using OPTN/UNOS Kidney Transplant Registry

    S. Sanoff,1 K. Ravindra,1 W. Irish.1,2

    1Duke University Medical Center, Durham, NC; 2CTI Consulting, Raleigh, NC.

    Introduction:Belatacept (BEL) was FDA approved for Kidney Transplantation (KTx) June 2011. It has largely been evaluated in two controlled trials (N Engl J Med 2016;374:333-43).…
  • 2018 American Transplant Congress

    Serum Cytokines as Markers of Influenza Infection Outcomes after Transplantation

    A. L'Huillier,1 V. Ferreira,1 C. Hirzel,1 E. Cordero,2 A. Limaye,3 G. Reid,4 J. Englund,3 E. Blumberg,5 A. Humar,1 D. Kumar.1

    1UHN, Toronto, Canada; 2REIPI, Seville, Spain; 3UOWMC, Seattle; 4LUMC, Chicago; 5UPenn, Philadelphia.

    Background:Influenza infection in transplant patients can be severe but factors predictive of outcome in this setting are unclear. The aim of the study was to…
  • 2018 American Transplant Congress

    A Calculator for Kidney Transplant Waitlist Outcomes under the New Kidney Allocation System

    A. Hart,1,2 N. Salkowski,2 A. Matas,3 B. Kasiske,2 J. Snyder,2 A. Israni.2

    1HCMC, Minneapolis; 2SRTR, Minneapolis; 3Univ of Minnesota, Minneapolis.

    BACKGROUND: Outcomes on the kidney transplant waiting list vary markedly by region and patient characteristics, and the new kidney allocation system (KAS) changed the probability…
  • 2018 American Transplant Congress

    Efficacy and Safety of Tocilizumab in Treatment of Acute Antibody Mediated Rejection

    K. Venkatachalam, D. Reem, M. Andrew, R. Delos Santos, T. Alhamad.

    Transplant Nephrology, Washington University, Saint Louis, MO; Transplant Nephrology, Ohio State University, Columbus, OH; Transplant Nephrology, Washington University, Saint Louis, MO; Transplant Nephrology, Washington University, Saint Louis, MO.

    Antibody mediated rejection continues to be one of the most detrimental complications of kidney transplant. Multiple therapeutic strategies focused on B cell and/or HLA antibody…
  • 2018 American Transplant Congress

    The Impact of Obesity on Incidence of Vascular Complications after Liver Transplantation: A Meta-Analysis

    R. Deng, Y. Shi, B. Huang, Y. Ma.

    Organ Transplantation Center, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong, China.

    Background: In response to the growing number of obese patients undergoing liver transplantation(LT), it is important to investigate the impact of obesity on post-transplant outcomes.…
  • 2018 American Transplant Congress

    Reducing Hospital Readmissions: Referral of High Risk Liver Transplant Patients to a Transitional Care Coordination(TCC) Program

    A. Masoumi,1 R. Barth,2 T. Stern,1 D. Bruno,2 J. LaMattina,2 S. Hanish.2

    1University of Maryland Medical Center, Baltimore, MD; 2Department of Surgery, University of Maryland School of Medicine, Baltimore, MD.

    One-fifth of Medicare patients are readmitted to the hospital an annual cost of $17.4 billion. The readmission rate among liver transplant patient populations at a…
  • « Previous Page
  • 1
  • …
  • 90
  • 91
  • 92
  • 93
  • 94
  • …
  • 155
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2026 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences